日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

c-Kit突变和定位状态作为犬肥大细胞瘤患者接受泼尼松和托西拉尼或长春碱治疗的疗效预测因子

Weishaar, K M; Ehrhart, E J; Avery, A C; Charles, J B; Elmslie, R E; Vail, D M; London, C A; Clifford, C A; Eickhoff, J C; Thamm, D H

Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs

犬自然发生的下尿路癌早期肿瘤对动脉内或静脉注射卡铂的反应

Culp, W T N; Weisse, C; Berent, A C; Reetz, J A; Krick, E L; Jackson, D E; Kass, P H; Clifford, C A; Sorenmo, K U

Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

脉冲式给药磷酸托西拉尼联合洛莫司汀治疗犬类不可切除的肥大细胞瘤

Burton J H, Venable R O, Vail D M, Williams L E, Clifford C A, Axiak-Bechtel S M, Avery A C, Thamm D H

Primary renal tumours in cats: 19 cases (1992-1998)

猫原发性肾脏肿瘤:19 例(1992-1998 年)

Henry, C J; Turnquist, S E; Smith, A; Graham, J C; Thamm, D H; O'Brien, M; Clifford, C A